MSB 0.43% $1.16 mesoblast limited

Ann: FDA Supports Accelerated Approval Pathway for Heart Failure, page-290

  1. 12,229 Posts.
    lightbulb Created with Sketch. 1089
    Hi Pledge,
    Just an opinion based on the INSTO being over subscribed.
    No one knows.
    I mean I could take 25% profit on my allocation so what's different.

    Just beats me why SI has put us in this dubious position chasing GvHD.

    If they once again turn around and say Data not good enough do the trial
    the dilution will be a killer.

    Lets hope thats not going to occur.

    Aloha.
    Last edited by Lopez: 13/03/24
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.16
Change
0.005(0.43%)
Mkt cap ! $1.318B
Open High Low Value Volume
$1.15 $1.17 $1.13 $3.743M 3.261M

Buyers (Bids)

No. Vol. Price($)
4 78561 $1.15
 

Sellers (Offers)

Price($) Vol. No.
$1.16 114667 4
View Market Depth
Last trade - 16.10pm 22/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.